Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.93
+0.04 (0.68%)
Feb 21, 2025, 4:00 PM EST - Market closed
Precision BioSciences Stock Forecast
DTIL's stock price has decreased by -54.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Precision BioSciences stock have an average target of 37.67, with a low estimate of 19 and a high estimate of 60. The average target predicts an increase of 535.24% from the current stock price of 5.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 10, 2025.
Analyst Ratings
The average analyst rating for Precision BioSciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold → Buy Upgrades $34 | Hold → Buy | Upgrades | $34 | +473.36% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +911.80% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +911.80% | Aug 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +911.80% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +911.80% | May 16, 2024 |
Financial Forecast
Revenue This Year
73.75M
from 48.73M
Increased by 51.35%
Revenue Next Year
20.43M
from 73.75M
Decreased by -72.30%
EPS This Year
2.66
from -15.96
EPS Next Year
-5.48
from 2.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 81.4M | 47.9M | 69.8M | |||
| Avg | 73.7M | 20.4M | 32.4M | |||
| Low | 67.2M | 4.9M | 12.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 67.0% | -35.1% | 241.8% | |||
| Avg | 51.3% | -72.3% | 58.5% | |||
| Low | 38.0% | -93.4% | -40.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.74 | -1.10 | 0.06 | ||
| Avg | 2.66 | -5.48 | -3.86 | ||
| Low | 2.56 | -9.60 | -6.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.